Literature DB >> 19165531

Weight loss in neurodegenerative disorders.

N A Aziz1, M A van der Marck, H Pijl, M G M Olde Rikkert, B R Bloem, R A C Roos.   

Abstract

Unintended weight loss frequently complicates the course of many neurodegenerative disorders and can contribute substantially to both morbidity and mortality. This will be illustrated here by reviewing the characteristics of unintended weight loss in the three major neurodegenerative disorders: Alzheimer's disease, Parkinson's disease and Huntington's disease. A common denominator of weight loss in these neurodegenerative disorders is its typically complex pathophysiology. Timely recognition of the underlying pathophysiological process is of crucial importance, since a tailored treatment of weight loss can considerably improve the quality of life. This treatment is, primarily, comprised of a number of methods of increasing energy intake. Moreover, there are indications for defects in the systemic energy homeostasis and gastrointestinal function, which may also serve as therapeutic targets. However, the clinical merits of such interventions have yet to be demonstrated.

Entities:  

Mesh:

Year:  2009        PMID: 19165531     DOI: 10.1007/s00415-009-0062-8

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  90 in total

1.  Nutritional evaluation of Huntington disease patients.

Authors:  L M Morales; J Estévez; H Suárez; R Villalobos; L Chacín de Bonilla; E Bonilla
Journal:  Am J Clin Nutr       Date:  1989-07       Impact factor: 7.045

Review 2.  Nutrition in advanced Alzheimer's disease.

Authors:  Heidi K White
Journal:  N C Med J       Date:  2005 Jul-Aug

Review 3.  Clinical practice. Diagnosis and initial management of Parkinson's disease.

Authors:  John G Nutt; G Frederick Wooten
Journal:  N Engl J Med       Date:  2005-09-08       Impact factor: 91.245

Review 4.  Olfaction in neurodegenerative disorder.

Authors:  Christopher Hawkes
Journal:  Adv Otorhinolaryngol       Date:  2006

5.  Change in body mass index and risk of incident Alzheimer disease.

Authors:  A S Buchman; R S Wilson; J L Bienias; R C Shah; D A Evans; D A Bennett
Journal:  Neurology       Date:  2005-09-27       Impact factor: 9.910

6.  Body weight is modulated by levels of full-length huntingtin.

Authors:  Jeremy M Van Raamsdonk; William T Gibson; Jacqueline Pearson; Zoe Murphy; Ge Lu; Blair R Leavitt; Michael R Hayden
Journal:  Hum Mol Genet       Date:  2006-03-28       Impact factor: 6.150

7.  Reduced reward processing in the brains of Parkinsonian patients.

Authors:  G Künig; K L Leenders; C Martin-Sölch; J Missimer; S Magyar; W Schultz
Journal:  Neuroreport       Date:  2000-11-27       Impact factor: 1.837

8.  Free-living daily energy expenditure in patients with Parkinson's disease.

Authors:  M J Toth; P S Fishman; E T Poehlman
Journal:  Neurology       Date:  1997-01       Impact factor: 9.910

9.  Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial.

Authors:  M Rösler; R Anand; A Cicin-Sain; S Gauthier; Y Agid; P Dal-Bianco; H B Stähelin; R Hartman; M Gharabawi
Journal:  BMJ       Date:  1999-03-06

10.  Dementia and Nutrition. Intervention study in institutionalized patients with Alzheimer disease.

Authors:  P Gil Gregorio; S P Ramirez Diaz; J M Ribera Casado
Journal:  J Nutr Health Aging       Date:  2003       Impact factor: 4.075

View more
  38 in total

1.  Frailty syndrome and all-cause mortality in demented patients: the Italian Longitudinal Study on Aging.

Authors:  Vincenzo Solfrizzi; Emanuele Scafato; Vincenza Frisardi; Daniele Sancarlo; Davide Seripa; Giancarlo Logroscino; Marzia Baldereschi; Gaetano Crepaldi; Antonio Di Carlo; Lucia Galluzzo; Claudia Gandin; Domenico Inzitari; Stefania Maggi; Alberto Pilotto; Francesco Panza
Journal:  Age (Dordr)       Date:  2011-04-26

Review 2.  Different models of frailty in predementia and dementia syndromes.

Authors:  F Panza; V Solfrizzi; V Frisardi; S Maggi; D Sancarlo; F Adante; G D'Onofrio; D Seripa; A Pilotto
Journal:  J Nutr Health Aging       Date:  2011-08       Impact factor: 4.075

3.  Weight loss and incident dementia in elderly Yoruba Nigerians: a 10-year follow-up study.

Authors:  Adesola Ogunniyi; Su Gao; Frederick W Unverzagt; Olusegun Baiyewu; Oyewusi Gureje; James Tat Nguyen; Valerie Smith-Gamble; Jill R Murrell; Ann M Hake; Kathleen S Hall; Hugh C Hendrie
Journal:  Int Psychogeriatr       Date:  2010-08-25       Impact factor: 3.878

4.  Body composition in Spinocerebellar ataxia type 3 and 10 patients: Comparative study with control group.

Authors:  Christiane de M B Almeida Leite; Maria Eliana M Schieferdecker; Caroline Frehner; Renato P Munhoz; Tetsuo Ashizawa; Hélio A G Teive
Journal:  Nutr Neurosci       Date:  2018-05-07       Impact factor: 4.994

Review 5.  Energy deficit in Huntington disease: why it matters.

Authors:  Fanny Mochel; Ronald G Haller
Journal:  J Clin Invest       Date:  2011-02-01       Impact factor: 14.808

Review 6.  Weight loss and undernutrition in community-dwelling patients with Alzheimer's dementia: From population based studies to clinical management.

Authors:  E Droogsma; D van Asselt; P P De Deyn
Journal:  Z Gerontol Geriatr       Date:  2015-05-20       Impact factor: 1.281

Review 7.  Weight Loss in Patients with Dementia: Considering the Potential Impact of Pharmacotherapy.

Authors:  Bart A A Franx; Ilse A C Arnoldussen; Amanda J Kiliaan; Deborah R Gustafson
Journal:  Drugs Aging       Date:  2017-06       Impact factor: 3.923

8.  IRS2 increases mitochondrial dysfunction and oxidative stress in a mouse model of Huntington disease.

Authors:  Marianna Sadagurski; Zhiyong Cheng; Aldo Rozzo; Isabella Palazzolo; Gregory R Kelley; Xiaocheng Dong; Dimitri Krainc; Morris F White
Journal:  J Clin Invest       Date:  2011-09-19       Impact factor: 14.808

Review 9.  PGC-1α at the intersection of bioenergetics regulation and neuron function: from Huntington's disease to Parkinson's disease and beyond.

Authors:  Taiji Tsunemi; Albert R La Spada
Journal:  Prog Neurobiol       Date:  2011-11-09       Impact factor: 11.685

Review 10.  Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases.

Authors:  Jinsha Liu; Joey Paolo Ting; Shams Al-Azzam; Yun Ding; Sepideh Afshar
Journal:  Int J Mol Sci       Date:  2021-03-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.